Private Equity
In order to successfully secure follow on rounds of funding, startups must understand how to traverse the Traction Gap and what it takes to get from an initial product release to minimum viable traction.
3 min read · 23 August 2016
Brooklyn Bridge Ventures has closed on a $15.1 million second seed fund, according to a blog post from General Partner Charlie O'Donnell.
1 min read · 22 August 2016
Darwin Ventures has set out to raise a $100 million fourth fund of funds, according to a filing with the SEC.
1 min read · 22 August 2016
Retired NBA star Kobe Bryant unveiled a $100 million venture-capital fund to invest in technology, media and data companies, according to The Wall Street Journal.
1 min read · 22 August 2016
Canadian venture capital firm Impression Ventures has raised $20 million for its second fund, earmarked for investments in early-stage financial technology companies. Anchor investors in Fund II include FairVentures, a subsidiary of Fairfax Financial Holdings Ltd, as well as several family offices. Toronto-based Impression, founded in 2013 by Managing Partner Christian Lassonde, said the new fund will build on the record of Fund I, which backed online investment advisor Wealthsimple, receipt solutions provider Sensibill, and parking payments specialist HonkMobile. Impression said it will partner with FairVentures in insurance-related deal opportunities.
2 min read · 22 August 2016
Rothenberg Ventures has seen an exodus of support staff, according a story on TechCrunch.
1 min read · 19 August 2016
Santa Clara, California-based Vertical Venture Partners has closed its inaugural fund with $51.3 million in commitments, according to a regulatory document. The filing indicates the money was raised from 32 investors. The firm was founded a couple of years ago by David Schwab, a former managing director with Sierra Ventures.
1 min read · 19 August 2016
Canadian specialty pharmaceutical company Knight Therapeutics Inc (TSX: GUD) has committed $1 million to Genesys Ventures III, the third life sciences fund of Canadian venture capital firm Genesys Capital. Montréal-based Knight said the investment, made as part of a $130 million strategy, is its eighth in a life sciences fund. PE Hub Canada reported this week that Genesys raised $90 million in the initial close of Fund III, which is targeted to raise $125 million in total. Other disclosed fund investors include the Fonds de solidarité FTQ and HarbourVest Canada Growth Fund.
3 min read · 18 August 2016
Rob Salvagno, head of corporate development and Cisco Investments, chats about theme investing and his approach to M&A
5 min read · 18 August 2016
The Fonds de solidarité FTQ has made a $15 million capital commitment to Genesys Ventures III, the third life sciences fund of Canadian venture capital firm Genesys Capital. The Fonds said the investment is consistent with its strategy of working with specialized funds with a market history in Québec. PE Hub Canada reported this week that Toronto-based Genesys raised $90 million in the initial close of Fund III, which is targeted to raise $125 million in total. The Fonds was one of 14 limited partners that participated in the initial close. Another was HarbourVest Canada Growth Fund.
2 min read · 18 August 2016
